Viewing StudyNCT00207168



Ignite Creation Date: 2024-05-05 @ 11:59 AM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00207168
Status: COMPLETED
Last Update Posted: 2011-04-22
First Post: 2005-09-12

Brief Title: To Assess Compliance With a Once-daily Regimen of Lamivudine Efavirenz and Didanosine
Sponsor: Bristol-Myers Squibb
Organization: Bristol-Myers Squibb

Conditions & Keywords Data

Conditions:
Name
AIDS
Keywords: